LEF1 and acute lymphoblastic leukemia: Similarly, Wang and Zhang [133] found that low expression of LEF1 is a biomarker of an aggressive subtype of T‐ALL called early T‐cell precursor, suggesting that including LEF1 with traditional immune‐phenotyping can enhance the diagnosis of early T‐cell precursor.